1 Sultan Qaboos University Hospital, Muscat, OMAN.
2 Sultan Qaboos University, College of Medicine and Health Sciences, Muscat, OMAN.
3 INSERM, U665, F-75015 Paris, France; Laboratoire d’Excellence GR-EX, Paris, France.
| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
explore the incidence of vaso-occlusive crisis (VOC) in Blood Group “O”
sickle cell disease (SCD) patients, and correlate it with the blood
group and thrombospondin (TSP) levels.
|Table 1. vWF:Ag, vWF:CBA, FVIII:C, Thrombospondin [TSP 1 and TSP 2] levels [Median, IQ range] with Age [Mean+SD] & ABO blood Group distribution in SCD patients in steady state[n=72].|
|Table 2. Age, [Mean+SD], Clotting times, Fibrinogen, vWF:Ag, vWF:CBA, FVIII:C, Thrombospondin [TSP 1 and TSP 2] levels [Median, IQ range] in the SCD patients in steady-state and VOC’s and in “O” blood group patients.|
|Table 3. Age [Mean+SD], vWF: Ag, vWF: CBA, FVIII: C, Thrombospondin [TSP 1 and TSP 2] levels [Median, IQ range] in the SCD patients cohort group 1[>4 VOC’s /yr.] and group 2 [<4 VOC’s/yr.].|
AcknowledgementsWe wish to thank the Hospital Administration for allowing the use of hospital data. This work was supported by a research grant no. IG/MED/HAEM/10/02.